1. Home
  2. ABVX vs CCIR Comparison

ABVX vs CCIR Comparison

Compare ABVX & CCIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • CCIR
  • Stock Information
  • Founded
  • ABVX 2013
  • CCIR 2021
  • Country
  • ABVX France
  • CCIR United States
  • Employees
  • ABVX N/A
  • CCIR N/A
  • Industry
  • ABVX
  • CCIR
  • Sector
  • ABVX
  • CCIR
  • Exchange
  • ABVX Nasdaq
  • CCIR NYSE
  • Market Cap
  • ABVX 407.6M
  • CCIR 351.0M
  • IPO Year
  • ABVX N/A
  • CCIR 2024
  • Fundamental
  • Price
  • ABVX $5.89
  • CCIR $11.17
  • Analyst Decision
  • ABVX Buy
  • CCIR
  • Analyst Count
  • ABVX 8
  • CCIR 0
  • Target Price
  • ABVX $34.63
  • CCIR N/A
  • AVG Volume (30 Days)
  • ABVX 328.4K
  • CCIR 500.9K
  • Earning Date
  • ABVX 03-24-2025
  • CCIR 01-01-0001
  • Dividend Yield
  • ABVX N/A
  • CCIR N/A
  • EPS Growth
  • ABVX N/A
  • CCIR N/A
  • EPS
  • ABVX N/A
  • CCIR 0.16
  • Revenue
  • ABVX $11,172,999.00
  • CCIR N/A
  • Revenue This Year
  • ABVX $371.31
  • CCIR N/A
  • Revenue Next Year
  • ABVX N/A
  • CCIR N/A
  • P/E Ratio
  • ABVX N/A
  • CCIR $68.71
  • Revenue Growth
  • ABVX 135.94
  • CCIR N/A
  • 52 Week Low
  • ABVX $5.50
  • CCIR $9.92
  • 52 Week High
  • ABVX $16.63
  • CCIR $12.80
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 36.23
  • CCIR N/A
  • Support Level
  • ABVX $5.60
  • CCIR N/A
  • Resistance Level
  • ABVX $7.85
  • CCIR N/A
  • Average True Range (ATR)
  • ABVX 0.61
  • CCIR 0.00
  • MACD
  • ABVX -0.09
  • CCIR 0.00
  • Stochastic Oscillator
  • ABVX 12.89
  • CCIR 0.00

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About CCIR COHEN CIRCLE ACQUISITION CORP I

Cohen Circle Acquisition Corp I is a blank check company.

Share on Social Networks: